Tech, energy, and retail stocks popped ahead of a flat market.
We look under the hood at the quarter’s Morningstar Style Box trends and their (lack of) impact on investors.
Have stocks really been "routed" and "roiled"? So far, not so much.
U.S. stocks and bonds remain little changed from the second quarter
Following a disciplined investment strategy can help you keep more of what your fund holdings earn.
ARK Investment’s Cathie Wood and Research Affiliates Rob Arnott spar over Tesla’s future.
Debt-ceiling fights and government shutdowns have been nonevents for stocks, with one big exception.
These wide- and narrow-moat stocks have suffered losses lately and are now trading in 4- and 5-star range.
Making rapid-fire shifts to take advantage of market trends is easier said than done.
We think the market is over-reacting to new drug pricing proposals, creating a buying opportunity.
For those willing to take on extra risk, the Chinese equity market’s recent correction provides investors with undervalued opportunities.
Balanced funds can play a useful role, but target-date funds look more compelling overall.
We look at emerging-markets debt through the Morningstar Emerging Markets Bond Index.
Some guidelines on figuring out if an annuity makes sense for you, and if so, how much to allocate.
Retailers posted solid numbers this earnings season, but we think their stocks are, in general, overbought--with some exceptions.
Our most recent study of investor returns reveals a persistent gap between reported total returns and what investors actually earn.
We take a closer look at popular retirement savings estimates.
As second-quarter earnings season winds down, we take a look at our analysts’ valuation changes across sectors.
The order of when things happen has implications for retirement savers, too.
As value slows down, tech is back in the driver's seat.
SPACs and other new companies may not be the best way to capitalize on growing EV adoption.
Value stocks struggled in July, but we continue to see this category as the best opportunity for long-term investors.
The order of when things happen can be your friend or your foe.
But signs build that the value rally has run out of steam.
A regulatory crackdown has left some big names at cheap prices.
Crypto can be incredibly complicated, but understanding the basic terminology is a good place to start.
Here’s what to know as the company starts trading publicly.
These seven charts show bond markets recovered, and stocks posted broad gains.
The cryptocurrency has generated massive gains at times, but extreme volatility will likely rule it out for many conventional investors.
These stocks struggled in the second quarter but are also trading at bargain prices.
As the oil slide dents the energy stock rally, only a few bargains have emerged.
The path to passing the plan may have changed, but its expected impact on the market has not.
Ethereum has the potential to revolutionize the entire financial landscape, but this cryptocurrency is a high-risk investment asset.
Tech stock revival boosts sustainable strategies.
The fund stands out for its focus on companies with a strong competitive advantage that can sustain and grow their dividends over time.
Bond markets recover and stocks post broad gains.
Energy and tech stocks lead as the U.S. market rally continued
A look at revival of large growth stocks, and the ebb of small value.
A Q&A with Adasina Social Capital and Activest on muni bonds as the intersection of finance and policy.
These funds rode momentum stocks higher, but some didn’t pivot with the value rally.
The value rotation has given new life to laggard equity-income strategies.
This type of investing is not for the faint of heart, but we still see value in several of these companies.
Morningstar Indexes through a geographic revenue lens.
It's arguably the best donor-advised fund affiliated with an asset-management firm for donors who plan to maintain higher account balances.
These wide-moat stocks are currently undervalued.
Should I be investing in disruptive technologies today?
The financial technology startup may not be a household name, but it has been a key to success for many firms.
These funds had the largest holdings of the drugmaker's stock before it soared.
As the value rotation continues, healthcare and tech names lag.
These stocks offer solid dividends and low ESG risk.